Extracorporeal Shock Wave Therapy in Patients With Lipedema

Starting soon · Not applicable

Conditions studied: Lipedema

In brief

Lipedema is a chronic adipose tissue disorder characterized by pain, tenderness, disproportionate fat accumulation, and impaired quality of life. Extracorporeal shock wave therapy (ESWT) has been proposed as a non-invasive treatment option that may improve pain and tissue characteristics in patients with lipedema. The aim of this prospective interventional study is to evaluate the effects of ESWT on pain intensity, quality of life, functional outcomes, and ultrasonographic findings in patients diagnosed with lipedema. Participants will receive a standardized ESWT protocol consisting of six treatment sessions over a two-week period. Clinical assessments and ultrasonographic examinations will be performed before and after treatment.

Key facts

Study ID

NCT07683559

Run by

Atlas University

People needed

40

Starts

2026-07-01

Expected to finish

2027-01-01

Last updated by the study team

2026-07-06

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female participants aged 18 to 75 years
• Clinical diagnosis of lipedema
• Willingness to participate and provide written informed consent
• Ability to comply with study procedures and follow-up assessments

You may not qualify if…

• Pregnancy or breastfeeding
• Active infection in the treatment area
• Malignancy
• Severe cardiovascular disease
• Coagulation disorders or current anticoagulant therapy
• Previous ESWT treatment within the last 6 months
• Severe psychiatric or cognitive disorders interfering with study participation
• Any condition deemed by the investigator to make participation unsafe

Where it is running

• Kanuni Sultan Suleyman Training and Research Hospital — Istanbul, Istanbul, Turkey (Türkiye)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.